US FDA approves new drug to prevent AIDS

The U.S. Food and Drug Administration (FDA) has approved a new drug that could help end the AIDS epidemic. It is a biannual antiviral injection, produced by the company Gilead for the prevention of HIV. The American media reported.

The launch of the drug, which will be marketed under the name Yeztugo, will however face a series of obstacles, including the cuts proposed by the Donald Trump administration to federal funding for AIDS prevention.

According to WHO data, the epidemic has caused approximately 1.3 million new infections and contributed to the deaths of 630,000 people worldwide in 2023. "In the United States alone, there are 700 new cases and 100 HIV-related deaths every week," said Daniel O'Day, CEO of Gilead.